Search

… company dedicated to changing lives through transformative RNA therapies, today announced it will present preclinical data for its proprietary Axiomer™ RNA editing technology platform and its AX-0810 pipeline program …

… company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer ™ RNA editing technology platform today announced that Company …

… company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer® RNA editing technology platform, today announced the Annual …

… programs supports ProQR’s strategic focus on Axiomer® RNA editing platform technology and continued advancement of …

… company dedicated to changing lives through transformative RNA therapies, today announced it has again successfully … filed against a key patent for its ADAR-mediated RNA editing platform Axiomer™. The opposition was filed in …

… Officer role, with leadership oversight of Axiomer ® RNA-editing platform technology John Maraganore, PhD, former …

… to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare … 10 (LCA10). Presentation title :  Proof-of-concept for RNA-editing oligonucleotide QR-110 for treatment of inherited …

… to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare … with LCA10 and preclinical data for ProQR’s Axiomer ® RNA-editing technology. Abstract titles: ○   Proof-of-concept …

… (SAB).  In vivo proof of concept data for novel Axiomer ®  RNA editing platform technology presented at the OTS meeting and …

… A. Beal to Scientific Advisory Board to Focus on Axiomer® RNA A-to-I Editing Technology Key Updates Dr. Peter A. Beal joins … of RNA-based therapeutics, particularly in the area of RNA editing. As an expert in the field of ADAR and A-to-I …